How to spot a fake GLP-1 weight-loss drug before you buy (McAfee) This is also supported by the fact that more than 330 companies are currently engaging in the development of GLP-1s from Big Pharma to emerging start-ups and the market debut of the as of yet unauthorised retatrutide, which is a new GLP-1 active pharmaceutical ingredient (API) developed by Eli Lilly, has already made waves in weight-loss and has been nicknamed Triple G
The HCG Institute The HCG Institute is a telemedicine platform that connects patients nationwide with licensed medical providers for weight management
Because they have personally experienced a reduced desire for food, they are more likely to anticipate a decline in overall demand, translating into lower revenues and profitability expectations for restaurants, grocery stores, and food manufacturers
Other notable adverse effects include: Injection site reactions (redness, itching, or discomfort) Fatigue Hypoglycemia (particularly when combined with insulin or sulfonylureas) Increased heart rate (mild elevation) Alopecia/hair loss (more common in weight management indication) Serious but less common risks include pancreatitis and gallbladder disease, which require prompt medical attention if symptoms develop
Common side effects include fatigue, nausea, insomnia, dehydration, and digestive problems
Zepbound also carries a second indication for moderate to severe obstructive sleep apnoea, added in December 2024